I’ll return the Excel spreadsheet survey with info for MCW outside of the dev 
list. 

MCW uses RESULT_DATE for the i2b2 “START_DATE” for lab facts.  START_DATE being 
a very poor name imposed by the i2b2 schema, it’s really just “some date” for a 
fact without any explicit context – hence the difference choices we will find 
between sites. It is also the “only date” that can be used to ask time relative 
questions of any given set of  facts in i2b2 unless we start creating related 
concepts or being inventive with modifier codes. I know of no example of i2b2 
modifier codes modifying the _date_ of a fact as opposed to the _value_. I 
think the schema would support it in principle but I have no idea if the client 
and generated queries would. This would also be a long term major ETL 
development task.

We do have all three of order_date, specimen_date and result_date from our Epic 
source data. But specimen date is only partially available, we are at the mercy 
of manual data entry and data validation upstream of us in the system. That is, 
at least in part, why MCW made the expedient choice of making RESULT_DATE our 
anchor for lab facts, it was the “best” one that was consistently available in 
the large.

Are the max difference questions for the different date types to be answered in 
the limited context of only to A1C values, or all lab results in our source 
system (or some broader subset)? 

I fear a simple max difference is going to be non-robust, uninformative, and 
look very bad (or even nonsensical) for us. Some work flows upstream (at least 
at MCW) for entering lab results into the EHR use manual data abstraction, and 
others use (at times broken) automated abstraction with poorly mapped date 
field semantics. There is going to be some percentage of completely bogus date 
values. To truly assess the lag between the different lab date semantics will 
probably take calculating percentiles of the differences for individual lab 
tests – this is obviously more effort and we will need guidance on how soon an 
answer is needed for it to be useful and if it is worth the effort and/or worth 
the wait. 

Thank you,

 Alex Stoddard
Biomedical Informatics Software Engineer
CTSI
Medical College of Wisconsin



Date: Wed, 25 Jan 2017 08:29:17 -0600
    From: "Al'ona Furmanchuk" <[email protected]>
    To: Dan Connolly <[email protected]>
    Cc: Bernard Black <[email protected]>,
        "<[email protected]>" <[email protected]>
    Subject: Re: [gpc-informatics] #551: next-D labs for cohort selection:
        fasting glucose, HbA1c
    Message-ID:
        <cadevuy6gxhn009napqyucrnjukds1zodzpw6fwyovrk7cy9...@mail.gmail.com>
    Content-Type: text/plain; charset="utf-8"
    
    Before we go toward changes, lets just see if we need to. I would
    appreciate if each site could fill up attached form and send back to me. I
    filled some sites based on this discussion. Please, check and correct if I
    got it wrong.
    Alona.
    
 

_______________________________________________
Gpc-dev mailing list
[email protected]
http://listserv.kumc.edu/mailman/listinfo/gpc-dev

Reply via email to